Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort.
BACKGROUND
Mammographic density is a strong predictor of breast cancer risk and is increased by hormone replacement therapy (HRT). Some associations with genetic polymorphisms in enzymes involved in estrogen metabolism have been described. This cross-sectional analysis examined the relation between mammographic density and the CYP1A2*1F and COMT Val58 Met polymorphisms among 332 breast cancer cases and 254 controls in the Hawaii component of the Multiethnic Cohort.


METHODS
Mammographic density, before diagnosis in cases, was quantified by using a validated computer-assisted method. Blood samples were genotyped by standard PCR/RFLP methods. Adjusted mean percent density was calculated by genotype using mixed models with the unstructured covariance option.


RESULTS
A positive association between the C allele in the CYP1A2*1F gene and percent density, but not the dense area, was suggested (p = 0.11). The relation was limited to controls (p = 0.045), postmenopausal women not using HRT (p = 0.08), and normal weight subjects (p = 0.046). We did not observe any relation between the COMT Val58 Met polymorphism and breast density.


CONCLUSIONS
The lack of an association between the CYP1A2 genotype and the size of the dense areas suggests an effect on the non-dense, i.e., fatty breast tissue. The discrepancies among studies may be due to differential susceptibility; changes in enzyme activity as a result of the CYP1A2*1F polymorphism may influence breast tissue differently depending on hormonal status. Larger studies with the ability to look at interactions would be useful to elucidate the influence of genetic variation in CYP1A2 and COMT on the risk of developing breast cancer.
Takata
Yumie
Y
Cancer Research Center of Hawaii, 1236 Lauhala Street, Honolulu, HI, USA. ytakata@fhcrc.org <ytakata@fhcrc.org>
Maskarinec
Gertraud
G
Le Marchand
Loïc
L
D000368:Aged; D001943:Breast Neoplasms / Q000209:etiology* / Q000235:genetics; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D015331:Cohort Studies; D019388:Cytochrome P-450 CYP1A2 / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008137:Longitudinal Studies; D008327:Mammography; D008875:Middle Aged; D011110:Polymorphism, Genetic
D019388:Cytochrome P-450 CYP1A2; D002394:Catechol O-Methyltransferase